Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Blood-retina barrier failure and vision loss in neuron-specific degeneration
Elena Ivanova, … , Glen T. Prusky, Botir T. Sagdullaev
Elena Ivanova, … , Glen T. Prusky, Botir T. Sagdullaev
Published March 19, 2019
Citation Information: JCI Insight. 2019;4(8):e126747. https://doi.org/10.1172/jci.insight.126747.
View: Text | PDF
Research Article Ophthalmology Vascular biology

Blood-retina barrier failure and vision loss in neuron-specific degeneration

  • Text
  • PDF
Abstract

Changes in neuronal activity alter blood flow to match energy demand with the supply of oxygen and nutrients. This functional hyperemia is maintained by interactions among neurons, vascular cells, and glia. However, how changing neuronal activity prevalent at the onset of neurodegenerative disease affects neurovascular elements is unclear. Here, in mice with photoreceptor degeneration, a model of neuron-specific dysfunction, we combined the assessment of visual function, neurovascular unit structure, and blood-retina barrier permeability. We found that the rod loss paralleled remodeling of the neurovascular unit, comprising photoreceptors, retinal pigment epithelium, and Muller glia. When substantial visual function was still present, blood flow became disrupted and the blood-retina barrier began to fail, facilitating cone loss and vision decline. Thus, in contrast to the established view, the vascular deficit in neuronal degeneration is not a late consequence of neuronal dysfunction but is present early in the course of disease. These findings further establish the importance of vascular deficit and blood-retina barrier function in neuron-specific loss and highlight it as a target for early therapeutic intervention.

Authors

Elena Ivanova, Nazia M. Alam, Glen T. Prusky, Botir T. Sagdullaev

×

Figure 7

Disruption of inner blood-retina barrier is associated with displaced retinal pigment epithelium.

Options: View larger image (or click on image) Download as PowerPoint
Disruption of inner blood-retina barrier is associated with displaced re...
(A) In WT mice, both inner and outer blood-retina barrier (BRB) were intact, as revealed by claudin5 expression in the retinal blood vessels and the absence of plasmalemma vesicle-associated protein (PLVAP) labeling. (B) In rd10 mice, compromised BRB was evident by PLVAP labeling of the exposed choroid (arrowheads, magenta) and fenestrated retinal blood vessels (arrows). (C and D) Retinal pigment epithelium (RPE) cells labeled by phalloidin Alexa Fluor 488 (arrowheads) surrounded fenestrated retinal blood vessel (arrows, PLVAP) in rd10 mice. (E) Transmitted light photograph of the isolated rd10 retina at P200 revealed displaced RPE cells attached to retinal capillaries (pigmented patches). (F–K) Capillaries associated with RPE had diminished expression of claudin5 (green) and high levels of PLVAP (magenta) and were leaky (albumin, blue, arrows). In contrast, structurally intact regions outside of displaced RPE expressed exclusively claudin5 and were not leaky (arrowheads). (J and K) A magnified region from E–I. (L) Distribution of fenestrated capillaries across retinal poles. Scale bars: 1 mm (A and B); 50 μm (C and D); 100 μm (E–K). Average ± SD (6 mice, each measurement). Two-tailed t test, *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts